($) USD (Default)
  • ($) AUD
  • (€) EUR
  • ($) CAD
  • ($) NZD
  • (£) GBP

ARA-290 Peptide Vial

$10.41$21.64

Laboratory research findings have unveiled the multitude of benefits associated with ARA-290:

  • Reduction in HbA1c levels and improvement in cholesterol profiles.
  • Alleviation of neuropathic pain and facilitation of wound healing.
  • Suppression of inflammatory pathways.
  • Induction of neuroprotective effects in diabetic neuropathy through the stimulation of blood vessel growth and promotion of cell survival.
  • Pain-relieving and neuroprotective effects on the brain without stimulating red blood cell production.
  • Potential clinical trial benefits for individuals with diabetes and autoimmune sarcoidosis.
  • Immune-modulatory and wound healing stimulation in people with diabetes.
  • Possible treatment implications for systemic lupus erythematosus (SLE) using this medication peptide.
  • Demonstration of anti-inflammatory properties through paracrine signaling and engagement with the innate repair receptors of erythropoietin ARA-290.

492 in stock

First time customer gets 15% discount code = 1storder

ARA-290 Peptide Vial 2mg Norway

The ARA-290 peptide vial represents a promising and exceptional compound that exhibits remarkable potential in enhancing tissue repair and reducing inflammation across various conditions including multiple sclerosis. As a distinguished member of the erythropoietin (EPO) family that interacts selectively with the innate repair receptor which mediates tissue protection. ARA290 effectively replicates the protective and reparative effects of EPO, while skillfully evading undesirable side effects.

Derived from meticulous scientific research, ARA290 peptide stands as a synthetic marvel, meticulously constructed using 11 strategically chosen amino acids. Initially formulated to address the relentless discomfort associated with neuropathic pain resulting from nerve damage, the compound’s remarkable capacity for tissue repair and potent anti-inflammatory characteristics have captured the attention of experts in recent times.

Norway ARA290 peptide interacts with the EPO receptor expressed in various tissues like the brain, heart, kidneys, and liver. Binding to the EPO receptor, ARA290 activates signaling pathways promoting cell survival, proliferation, and differentiation, thereby facilitating tissue repair and regeneration.

Furthermore, clinical studies have shown efficacy that ARA-290 peptide vial exhibits anti-inflammatory properties, inhibiting pro-inflammatory cytokines including tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β), while stimulating the release of  cytokines like interleukin-10 (IL-10) which are anti-inflammatory. This unique dual action showcases the potential of Norway ARA-290 peptide vial for various conditions related to tissue damage and inflammation.


ARA-290 Peptide Vial Benefits Norway

Promotes Tissue Repair and Tissue Protection

The ARA-290 peptide has demonstrated its ability to optimize tissue repair across conditions like diabetic nephropathy, stroke, and heart failure. It achieves this by effectively reducing HbA1c levels and enhancing cholesterol profiles.

Reduces inflammation

The ARA-290 peptide vial has been proven to possess unique and engaging anti-inflammatory properties that can offer benefits for various conditions like rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. Scientific research has shown that these effects are achieved through the paracrine signaling and innate repair receptors of erythropoietin ARA-290.

Protects against oxidative stress

In preclinical and clinical studies, ARA290 peptide has demonstrated its efficacy in safeguarding against oxidative stress, a known contributor to conditions like Alzheimer’s disease, Parkinson’s disease, and cardiovascular disease.

Improves cognitive function

The ARA-290 peptide has demonstrated promising results in enhancing cognitive function in Norway animal models of Alzheimer’s disease and traumatic brain injury.

Tested to help with diabetes

According to previous research, ARA290 has shown potential benefits for diabetes and autoimmune sarcoidosis. Further studies are currently exploring its ability to alleviate neuropathic pain and induce neuroprotective effects in diabetic neuropathy by promoting blood vessel growth and cell survival.

Wound healing stimulator

Ongoing investigation into chronic diabetes wound repair is being conducted, along with studies on the modulation of the immune system and its potential application in treating systemic lupus erythematosus (lupus or SLE).

There is also the option Norway to buy ARA-290 Nasal Spray or buy ARA-290 Pre Mixed Peptide.


References:

[1] https://pubmed.ncbi.nlm.nih.gov/ 25387363/


Sequence: ZEQLERALNSS
Molecular Formula: C51 E1016021
Molecular Weight: 1257.3 g/mol

ARA-290 HPLC Certificates


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Norway Direct Sarms website is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.

Related Products

You may also like…